PROCEPT BioRobotics Corporation - Common Stock (NQ:PRCT)Price and VolumeDetailed Quote
Top NewsMore NewsPerformance
52-Week Range
53.6% below 52-week high
17.67
16.6652W Low
38.1152W High
1 Week
5.4% below 1-week high
16.741W Low
18.671W High
PROCEPT BioRobotics Corporation - Common Stock (PRCT) traded between $16.66 and $38.11 over the past 52 weeks and last traded at $17.67, 53.6% below its 52-week high. Over the past week it ranged between $16.74 and $18.67.
Past 12 Months
1W
+$0.42
1M
-$5.09
3M
-$3.54
6M
-$6.11
YTD
-$13.09
1Y
-$17.57
PRCT was -49.9% over the past year, -25.7% over six months, -42.6% year to date, +2.4% in the last week.
12 Months vs Market
PRCT
DIA
SPY
QQQ
IWM
Over the past 12 months PRCT returned -49.9% versus DIA (Dow) +9.1%, SPY (S&P 500) +14.9%, QQQ (Nasdaq 100) +23.8% and IWM (Russell 2000) +14.2%.
Volume & Liquidity
0.05× 3-mo avg
Today 67,054
3-mo avg 1.5M
1W
1M
3M
6M
YTD
1Y
PRCT most recently traded 67,054 shares against a 3-month average daily volume of 1.5M. More NewsRead MoreFrequently Asked QuestionsIs PROCEPT BioRobotics Corporation - Common Stock publicly traded?
Yes, PROCEPT BioRobotics Corporation - Common Stock is publicly traded.
What exchange does PROCEPT BioRobotics Corporation - Common Stock trade on?
PROCEPT BioRobotics Corporation - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for PROCEPT BioRobotics Corporation - Common Stock?
The ticker symbol for PROCEPT BioRobotics Corporation - Common Stock is PRCT on the Nasdaq Stock Market
What is the current price of PROCEPT BioRobotics Corporation - Common Stock?
The current price of PROCEPT BioRobotics Corporation - Common Stock is 17.67
When was PROCEPT BioRobotics Corporation - Common Stock last traded?
The last trade of PROCEPT BioRobotics Corporation - Common Stock was at 10/05/26 10:09 AM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
|